The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of larotrectinib in pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive cancer: An expanded dataset.
 
Leo Mascarenhas
Consulting or Advisory Role - Amgen; Bayer (Inst)
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); E.R. Squibb Sons, LLC (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
(OPTIONAL) Uncompensated Relationships - Children's Oncology Group Foundation; The Pablove Foundation
 
Cornelis Martinus van Tilburg
Consulting or Advisory Role - Bayer; Novartis
 
Francois Doz
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Loxo; Roche; Servier; Tesaro
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Roche
 
C. Michel Zwaan
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; Janssen; Novartis; Roche; Sanofi; Takeda
Research Funding - Abbvie; Jazz Pharmaceuticals; Pfizer; Takeda
 
Catherine M. Albert
No Relationships to Disclose
 
Claudia Blattman
Consulting or Advisory Role - Bayer
 
Birgit Geoerger
Consulting or Advisory Role - AZD; Boehringer Ingelheim; Novartis
 
Steven G. DuBois
Consulting or Advisory Role - Amgen; Bayer
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Noah Federman
Stock and Other Ownership Interests - Reata Pharmaceuticals
Consulting or Advisory Role - Bayer; Loxo; Zelda Therapeutics
Speakers' Bureau - Bayer
Research Funding - Mirati Therapeutics
 
Ramamoorthy Nagasubramanian
No Relationships to Disclose
 
Alberto S. Pappo
Honoraria - Bayer; Lilly; Roche
Consulting or Advisory Role - Debbio; EUSA Pharma; Loxo/Bayer; Merck
 
Tanya Carens Watt
No Relationships to Disclose
 
Ricarda Norenberg
Employment - Bayer Health (I)
Consulting or Advisory Role - Bayer Health (Inst)
 
Marc Mardoche Fellous
Employment - Bayer
Consulting or Advisory Role - Bayer (I)
 
Esther A. De La Cuesta
Employment - Bayer
Leadership - Bayer
Stock and Other Ownership Interests - Bayer
 
Theodore Willis Laetsch
Consulting or Advisory Role - Advanced Microbubbles; AI Therapeutics; Aptitude Health; Bayer; Cellectis; Clinical Education Alliance; Deciphera; Jazz Pharmaceuticals; Jumo Health; Massive Bio; Med Learning Group; Medscape; Novartis; Physicans' Education Resource; Y-mAbs Therapeutics
Research Funding - Abbvie (Inst); Amgen (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Epizyme (Inst); Foundation Medicine (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Jubilant Pharmaceuticals (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Novella Clinical (Inst); Pfizer (Inst); SERVIER (Inst); Turning Point Therapeutics (Inst)
 
Rui-hua Xu
No Relationships to Disclose